---
title: '[Retracted] Sulforaphane sensitizes human cholangiocarcinoma to cisplatin
  via the downregulation of anti‑apoptotic proteins'
date: '2024-04-05'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38577925/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240405180803&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'Following the publication of the above article and a corrigendum that
  was published in October 2023 to address the issue of misplaced control β‑actin
  western blots comparing between Figs. 3 and 4A (doi: 10.3892/or.2023.8646), an attentive
  reader drew to the authors'' attention that the first author had apparently made
  additional unreported corrections to the revised version of Fig. 4 presented in
  the corrigendum. Although these image discrepancies did not alter the study''s primary
  ...'
disable_comments: true
---
Following the publication of the above article and a corrigendum that was published in October 2023 to address the issue of misplaced control β‑actin western blots comparing between Figs. 3 and 4A (doi: 10.3892/or.2023.8646), an attentive reader drew to the authors' attention that the first author had apparently made additional unreported corrections to the revised version of Fig. 4 presented in the corrigendum. Although these image discrepancies did not alter the study's primary ...